Skip to content
Teneo
steve-meahl_1218
Deborah Nash
Portrait of Nicholas McDonagh
Portrait of Damien Ryan
Jan Hromadko
Matthew
Kelly Boxall headshot
Juliet Kayyem
Portrait of Kevin Kajiwara
Ursula Burns Headshot July 2023
Butters-Dan (Colour) (1)
Adante-Courtney (Color)
Diane McIntyre Headshot
Lisa Davis
Andrea Calise headshot
Van Jones
Portrait of James Crossland
Leo
Nick
Kathy Deveny
Portrait of Michael O'Keeffe
Sherman-Bethany (Color)
PDR Head Shot Hi Res
Jeff Sindone
Stephan Merkens
Melissa Mackreath
Andrea Calise headshot
Portrait of John Judge
Lisa Davis
Portrait of Robert Mead
Tim
Portrait of Paul Keary
Portrait of Senator George Mitchell
Monica Frassoni
Senator Dodd headshot
Adam Daifallah headshot
Rhea Siers
Colleen Hsia
Ginni Rometty
Lauren Chung Color
Oliver Letwin
Portrait of William J. Bratton
Kristen Hostetter
Chan-Galaxy
Alex Pigliucci New
Portrait of Kathleen Lacey
Dow_CEO_Andrew_Liveris060917
© 2019 | Kristina Sherk Photography | www.Kristinasherk.com

People

Menu

Matthew

Dr. Matthew Farleigh

Senior Consultant

Dr. Matthew Farleigh is a Senior Consultant with Teneo’s Management Consulting business, based in London.

Matthew advises clients across a broad range of industries and functions, though he has specific expertise in Medical Imaging, Energy, Industrials and De-carbonization topics. Matthew has also worked for a number of high-profile clients including Oil & Gas majors, global downstream chemicals companies and national gas distribution networks.

His experience includes a broad range of engagement types including CEO advisory support, pricing and packaging (opportunity assessment, solution design and strategic implementation), new product development, commercial due diligence, M&A support, new market entry, bid proposal development, white paper development, business case development, project management office support and separation management office support.

Matthew holds a PhD in Imaging Chemistry from King’s College London. His PhD thesis examined the design, synthesis, radiolabelling, in vitro and in vivo assessment of novel radioactive drugs for PET imaging.

Related Service Areas

Articles by Dr. Matthew Farleigh